𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A recombinant human interleukin-1β protects adriamycin-induced toxicity

✍ Scribed by Hirokazu Okumura; Takashi Yoshida; Hiroyasu Kaya; Sadaya Matano; Yoko Okabe; Shigeki Ohtake; Shinobu Nakamura; Tamotsu Matsuda

Publisher
Springer
Year
1993
Tongue
English
Weight
653 KB
Volume
7
Category
Article
ISSN
0921-299X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Human recombinant interleukin-1 receptor
Human recombinant interleukin-1 receptor antagonist blocks bone resorption induced by interleukin-1β but not interleukin-1α
✍ R. A. Chole; S. P. Tinling; B. T. Faddis 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 397 KB

Both interleukin-1 alpha (IL-1 alpha) and interleukin-1 beta (IL-1 beta) are powerful stimulators of bone resorption in vivo and in vitro. Interleukin-1 receptor antagonist (IL-1ra) binds to many interleukin-1 receptors. It does not activate the receptor and effectively blocks the action of IL-1 alp

Interleukin (IL)-1β toxicity to islet β
Interleukin (IL)-1β toxicity to islet β cells: Efaroxan exerts a complete protection
✍ Gianpaolo Papaccio; Antonio Graziano; Salvatore Valiante; Riccardo D'Aquino; Sal 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 371 KB

## Abstract Interleukin (IL)‐1β‐treated rat islets of Langerhans were exposed in vitro either to the imidazoline compound, Efaroxan, or to the selective inducible nitric oxide synthase (iNOS) inhibitor, 1400W, in a medium containing a high concentration of glucose (16.7 mmol/L). Our data have evide